A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia)

Clinical trial NCT00160667 · COMPLETED

Trial details

NCT number: NCT00160667
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuralgia, Postherpetic

Start date: 2004-10-11
Primary completion: 2006-01-05
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.